Clinical Trials Browser

Unknown × Carcinoma, Non-Small-Cell Lung × Neoadjuvant Therapy × Clear all

NCT04197076 2022-07-29

Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

Carcinoma, Non-Small-Cell Lung

NCT04968002 2021-07-20

Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01926483 2013-08-21

ZTOG-1202

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00398385 2013-08-12

Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Phase 2 Unknown

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01187290 2010-08-24

Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00616499 2009-02-09

Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Phase 2 Unknown

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms